These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 34455662)

  • 1. Early Clostridioides difficile infection characterizations, risks, and outcomes in allogeneic hematopoietic stem cell and solid organ transplant recipients.
    Obeid KM; Sapkota S; Cao Q; Richmond S; Watson AP; Karadag FK; Young JH; Pruett T; Weisdorf DJ; Ustun C
    Transpl Infect Dis; 2022 Feb; 24(1):e13720. PubMed ID: 34455662
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clostridioides difficile Infection and Risk of Acute Graft-versus-Host Disease among Allogeneic Hematopoietic Stem Cell Transplantation Recipients.
    Jabr R; El Atrouni W; Shune L; Telfah M; Gao G; He J; Abhyankar S; McGuirk J; Clough L
    Transplant Cell Ther; 2021 Feb; 27(2):176.e1-176.e8. PubMed ID: 33830032
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clostridioides difficile infection and recurrence among 2622 solid organ transplant recipients.
    Schluger A; Rosenblatt R; Knotts R; Verna EC; Pereira MR
    Transpl Infect Dis; 2019 Dec; 21(6):e13184. PubMed ID: 31571380
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A multicenter study to define the epidemiology and outcomes of Clostridioides difficile infection in pediatric hematopoietic cell and solid organ transplant recipients.
    Mayer EF; Maron G; Dallas RH; Ferrolino J; Tang L; Sun Y; Danziger-Isakov L; Paulsen GC; Fisher BT; Vora SB; Englund J; Steinbach WJ; Michaels M; Green M; Yeganeh N; Gibson JE; Dominguez SR; Nicholson MR; Dulek DE; Ardura MI; Rajan S; Gonzalez BE; Beneri C; Herold BC
    Am J Transplant; 2020 Aug; 20(8):2133-2142. PubMed ID: 32064754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clostridioides difficile infection in solid organ and hematopoietic stem cell transplant recipients: A prospective multinational study.
    Blumberg EA; Collins G; Young JH; Nguyen MH; Michonneau D; Temesgen Z; Origȕen J; Barcan L; Obeid KM; Belloso WH; Gras J; Corbelli GM; Neaton JD; Lundgren J; Snydman DR; Molina JM;
    Transpl Infect Dis; 2022 Feb; 24(1):e13770. PubMed ID: 34821423
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Incidence and Outcomes Associated With Clostridioides difficile Infection in Solid Organ Transplant Recipients.
    Hosseini-Moghaddam SM; Luo B; Bota SE; Husain S; Silverman MS; Daneman N; Brown KA; Paterson JM
    JAMA Netw Open; 2021 Dec; 4(12):e2141089. PubMed ID: 34964852
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epidemiology and outcomes of Clostridium difficile infection in allogeneic hematopoietic cell and lung transplant recipients.
    Dubberke ER; Reske KA; Olsen MA; Bommarito K; Cleveland AA; Silveira FP; Schuster MG; Kauffman CA; Avery RK; Pappas PG; Chiller TM
    Transpl Infect Dis; 2018 Apr; 20(2):e12855. PubMed ID: 29427356
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk Factors for Clostridioides Difficile Diarrhea In Solid Organ Transplantation Recipients.
    Ortiz-Balbuena J; Royuela A; Calderón-Parra J; Martínez-Ruiz R; Asensio-Vegas Á; Múñez E; Valencia-Alijo Á; Gutiérrez-Rojas Á; Ussetti P; Cuervas-Mons V; Segovia-Cubero J; Portolés-Pérez J; Ramos-Martínez A
    Transplant Proc; 2021 Dec; 53(10):2826-2832. PubMed ID: 34772488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Outcomes of C difficile infection in solid-organ transplant recipients: The National Inpatient Sample (NIS) 2015-2016.
    Mahatanan R; Tantisattamo E; Charoenpong P; Ferrey A
    Transpl Infect Dis; 2021 Feb; 23(1):e13459. PubMed ID: 32894617
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for Clostridioides (Clostridium) difficile infection following solid organ transplantation in children.
    Ochfeld E; Balmert LC; Patel SJ; Muller WJ; Kociolek LK
    Transpl Infect Dis; 2019 Oct; 21(5):e13149. PubMed ID: 31332916
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early Clostridium difficile infection during allogeneic hematopoietic stem cell transplantation.
    Kinnebrew MA; Lee YJ; Jenq RR; Lipuma L; Littmann ER; Gobourne A; No D; van den Brink M; Pamer EG; Taur Y
    PLoS One; 2014; 9(3):e90158. PubMed ID: 24662889
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clostridium difficile infection is associated with graft loss in solid organ transplant recipients.
    Cusini A; Béguelin C; Stampf S; Boggian K; Garzoni C; Koller M; Manuel O; Meylan P; Mueller NJ; Hirsch HH; Weisser M; Berger C; van Delden C;
    Am J Transplant; 2018 Jul; 18(7):1745-1754. PubMed ID: 29349869
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxigenic
    Keegan J; Buchan BW; Ledeboer NA; Zhou Z; Hong JC; Graham MB; Munoz-Price LS
    Infect Control Hosp Epidemiol; 2021 Mar; 42(3):287-291. PubMed ID: 32933595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of Clostridium difficile infection with outcomes of hospitalized solid organ transplant recipients: results from the 2009 Nationwide Inpatient Sample database.
    Pant C; Anderson MP; O'Connor JA; Marshall CM; Deshpande A; Sferra TJ
    Transpl Infect Dis; 2012 Oct; 14(5):540-7. PubMed ID: 22726461
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effective treatment of Clostridioides difficile infection improves survival and affects graft-versus-host disease: a multicenter study by the Polish Adult Leukemia Group.
    Piekarska A; Sadowska-Klasa A; Mensah-Glanowska P; Sobczyk-Kruszelnicka M; Drozd-Sokołowska J; Waszczuk-Gajda A; Kujawska J; Wilk M; Tomaszewska A; Zaucha JM; Giebel S; Gil L
    Sci Rep; 2024 Mar; 14(1):5947. PubMed ID: 38467719
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence Rates and Risk Factors of
    Ilett EE; Helleberg M; Reekie J; Murray DD; Wulff SM; Khurana MP; Mocroft A; Daugaard G; Perch M; Rasmussen A; Sørensen SS; Gustafsson F; Frimodt-Møller N; Sengeløv H; Lundgren J
    Open Forum Infect Dis; 2019 Apr; 6(4):ofz086. PubMed ID: 30949533
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clostridium difficile infection, a descriptive analysis of solid organ transplant recipients at a single center.
    Tsapepas DS; Martin ST; Miao J; Shah SA; Scheffert J; Fester K; Ma K; Lat A; Egan R; McKeen JT
    Diagn Microbiol Infect Dis; 2015 Apr; 81(4):299-304. PubMed ID: 25586932
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hospital-onset Clostridium difficile infection among solid organ transplant recipients.
    Donnelly JP; Wang HE; Locke JE; Mannon RB; Safford MM; Baddley JW
    Am J Transplant; 2015 Nov; 15(11):2970-7. PubMed ID: 26484839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Management of Clostridioides (formerly Clostridium) difficile infection (CDI) in solid organ transplant recipients: Guidelines from the American Society of Transplantation Community of Practice.
    Mullane KM; Dubberke ER;
    Clin Transplant; 2019 Sep; 33(9):e13564. PubMed ID: 31002420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Clostridioides difficile infection on the outcome of patients receiving a hematopoietic stem cell transplantation.
    Weber S; Scheich S; Magh A; Wolf S; Enßle JC; Brunnberg U; Reinheimer C; Wichelhaus TA; Kempf VAJ; Kessel J; Vehreschild MJGT; Serve H; Bug G; Steffen B; Hogardt M
    Int J Infect Dis; 2020 Oct; 99():428-436. PubMed ID: 32798661
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.